Hisayuki Kato   Kensei Naito   
Practica Oto-Rhino-Laryngologica 109(6) 371-381 2016年1月
At present, there are no high-impact biomarkers for deciding the course of treatment in patients with head and neck cancer. While smoking and alcohol abuse are among the most common risk factors for head and neck cancer, in the last decade, the hu...